Here, we attempted to explore whether Pygo1 participates in abnormal activation of Wnt signaling pathway I in human NSCLC and whether the interaction between Pygo1 and β-catenin affects lung cancer development. Here, PYGO1 is linked to non-small cell lung carcinoma.